ID: MRFR/MED/4408-HCR | February 2023 | Region: Global | 100 Pages
General Surgical Devices Market to reach USD 15.1 Billion at CAGR of 8.60% by the end of 2022-2030.
$15.1 Billion
8.60%
North America
2022-2030
General Surgical Devices Market Overview The General Surgical Devices Market is anticipated to reach USD 15.1 Billion by 2030 at 8.60% CAGR during the forecast period 2022-2030. Surgical equipment is normally used generically, however, some tools are specifically created for certain operations or surgeries. The healthcare systems of emerging countries are rapidly changing. Medical equipment demand is expected to rise as these countries' populations grow. Over two-thirds of the cost increase is due to rising illness load and the development of new medical therapies. During the predicted period, healthcare spending in China and India is expected to rise. Because of developments in minimally invasive surgical procedures and an increase in outpatient surgeries, the market is rising. As a result of the inflow of several new businesses into the industry, the market is predicted to grow even more and costs to decrease. The market is growing as a result of increased usage of minimally invasive technologies, rising chronic diseases, and rising healthcare spending. Noncommunicable diseases (NCDs), also known as chronic diseases, kill approximately 41 million people each year, accounting for roughly 71 percent of all deaths worldwide, according to the World Health Organization's (WHO) 2021 information sheet. Furthermore, according to the same source, NCDs claim the lives of nearly 15 million people aged 30 to 69 years old every year around the world.
Key Players
Some of key the players in the general surgical devices market are Johnson & Johnson Services, Inc. (U.S.), Erbe Elektromedizin GmbH (Germany), Conmed Corporation (U.S.), Integra LifeSciences (U.S.), Smith & Nephew (U.S.), 3M Healthcare (U.S.), CareFusion Corporation (U.S.), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (U.S.), Boston Scientific Corporation (U.S.), Medtronic Plc. (U.S.), Stryker Corporation (U.S.), Cadence Inc. (U.S.), Maquet Holding B.V. & CO. KG. (Germany), Olympus Corporations (U.S.), Grifols (Spain), Ortho-Clinical Diagnostics, Inc. (U.S.), SOFINA s.a (Biomérieux) (U.S.), Siemens Healthcare GmbH (Germany), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Accuray Incorporated (U.S.), Intuitive Surgical Inc. (U.S.), Medrobotics Corporation (U.S.), TransEnterix Surgical (U.S.), Meere Company (U.S.), Titan Medical (Canada), Verb Surgical (U.S.), Virtual Incision Corporation (U.S.), and others.
Intended Audience
Segmentation
The general surgical devices market is segmented on the basis of type, product, application, and end-user.
On the basis of type, the global general surgical devices market can be segmented into disposable surgical supplies, open surgery instrument, energy-based and powered instrument, minimally invasive surgery instruments, medical robotics and computer-assisted surgery devices, and others.
The disposable surgical supplies are segmented into surgical non-woven, examination and surgical gloves, general surgery procedural kits, needles and syringes, venous access catheters, and others. The surgical non-woven segment is further divided into disposable surgical masks, surgical drapes, surgical caps, surgical gowns, and others.
The open surgery instrument is segmented into retractor, dilator, and catheters. The energy-based and powered instruments are segmented into powered staplers and drill system. The minimally invasive surgery instruments are divided into laparoscope and organ retractor. The medical robotics and computer-assisted surgery devices are divided into adhesion prevention products and others.
On the basis of product, the general surgical devices market can be segmented into handheld devices, laparoscopic devices, electrosurgical devices, wound closure devices, trocars and access devices, and others.
On the basis of application, the general surgical devices market can be segmented into orthopedic surgery, cardiology, ophthalmology, wound care, audiology, thoracic surgery, urology and gynecology surgery, plastic surgery, neurosurgery, and others.
On the basis of end-user, the general surgical devices market can be segmented into hospitals, clinics, diagnostic centers, academic institutes, research centers, and others.
Research Methodology
Â
Sources: Annual reports, Press release, White paper, and Company presentation
Regional Analysis
The general surgical devices market consists of regions, namely, America, Europe, Asia Pacific, and the Middle East and Africa.
Americas dominated the general surgical devices market owing to the increasing number of surgical procedures, the presence of key players, favorable reimbursement policies, and numerous initiatives undertaken by the government to provide training sessions and access to advanced devices for physicians.
As per an article published by Time, Inc., until June 2017 there were more than 4,100 da Vinci units installed globally. This includes 2,703 in the U.S., 698 units in Europe, 538 units in Asia, and 210 units in the rest of the world. For instance, in April 2017, Intuitive Surgical, Inc. received the CE mark approval in Europe for the da Vinci X Surgical System that offers robotic-assisted surgeries at a lower cost for surgeons and hospitals.
Asia Pacific is anticipated to grow at a maximum pace during the forecast period due to rising investments along with the regional expansion. For instance, in February 2014, CryoLife, Inc. established a new subsidiary in the Asia Pacific region. This expansion will increase the presence of the subsidiary in the general surgery devices market in the Asia Pacific region.
The Middle East and Africa has the potential to emerge as a production hub for medical devices and large-scale development. The key factor contributing to this transformation is the low cost of product development in this region.Recent Development
General Surgical Devices Market, by Region
Report Attribute/Metric | Details |
---|---|
Market Size | 15.1 Billion |
CAGR | 8.60% (2022-2030) |
Base Year | 2021 |
Forecast Period | 2022-2030 |
Historical Data | 2020 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Type, Product, Application, and End-User |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Johnson & Johnson Services, Inc. (U.S.), Erbe Elektromedizin GmbH (Germany), Conmed Corporation (U.S.), Integra LifeSciences (U.S.), Smith & Nephew (U.S.), 3M Healthcare (U.S.), CareFusion Corporation (U.S.), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (U.S.), Boston Scientific Corporation (U.S.), Medtronic Plc. (U.S.), Stryker Corporation (U.S.), Cadence Inc. (U.S.), Maquet Holding B.V. & CO. KG. (Germany), Olympus Corporations (U.S.), Grifols (Spain), Ortho-Clinical Diagnostics, Inc. (U.S.), SOFINA s.a (Biomérieux) (U.S.), Siemens Healthcare GmbH (Germany), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Accuray Incorporated (U.S.), Intuitive Surgical Inc. (U.S.), Medrobotics Corporation (U.S.), TransEnterix Surgical (U.S.), Meere Company (U.S.), Titan Medical (Canada), Verb Surgical (U.S.), Virtual Incision Corporation (U.S.), and others. |
Key Market Opportunities |
|
Key Market Drivers |
|
On the basis of type, the General Surgical Devices Market can be segmented into disposable surgical supplies, open surgery instrument, energy-based and powered instrument, minimally invasive surgery instruments, medical robotics and computer-assisted surgery devices, and others.
Market is expected to exhibit a strong 8.60% CAGR over the forecast period from 2022 to 2030.
Growing demand for surgical procedures is the major driver for the General Surgical Devices Market.
Americas dominate the General Surgical Devices Market.
Leading players in the General Surgical Devices Market include Integra LifeSciences, Conmed Corporation, and 3M Healthcare, among others.